Skip to main content

Table 1 Patient characteristics

From: Customized chemotherapy based on epidermal growth factor receptormutation status for elderly patients with advanced non-small-cell lung cancer: a phase II trial

 

All

Gefitinib

VNR or GEM

P

Age (years)

    

Median (range)

80 (71–89)

81 (71–85)

79 (72–89)

0.11

Male:Female

20:34

5:17

15:17

0.09

ECOG PS

    

0:1

12:42

8:14

4:28

0.05

Histology

    

Adeno

37

21

16

< 0.001

Squamous

8

1

7

 

Other

9

0

9

 

Smoking history

    

Never

29

16

13

0.03

Former / current

25

6

19

 

Mutation type

    

Exon 19 del

6

6

―

―

Exon 21 L858R

14

14

―

 

Ex19del + L858R

2

2

―

 

Clinical stage

    

IIIB

20

9

11

0.78

IV

34

13

21

 
  1. ECOG PS: Eastern Cooperative Oncology Group Performance Status; GEM: gemcitabine; VNR: vinorelbine.